ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer

Zheng, Shangyou; Tian, Qing; Yuan, Yuan; Sun, Shuxin; Li, Tingting; Xia, Renpeng; He, Rihua; Luo, Yuming; Lin, Qing; Fu, Zhiqiang; Zhou, Yu*; Chen, Rufu*; Hu, Chonghui*广东省人民医院; 广东省心血管病研究所; 南方医科大学; 汕头大学; 中山大学; y
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH2023-11-28DOI: 10.1186/s13046-023-02854-3
10阅读
引用收藏
分享

摘要

Background Cancer-associated fibroblasts (CAFs) play pivotal roles in chemoresistance of pancreatic ductal adenocarcinoma (PDAC). However, the underlying mechanisms are poorly understood. Revealing the cross-talk network between tumor stroma and pancreatic cancer and developing effective strategies against oxaliplatin resistance are highly desired in the clinic. @@@ Methods High-throughput sequence was used to screened the key circRNAs transmitted by extracellular vesicles (EVs) from CAFs to pancreatic cancer cells. The associations between EV-packaged circBIRC6 and chemotherapy responsiveness were validated in a cohort of 82 cases of advanced PDAC patients. Then, the effects of EV-packaged circBIRC6 on CAF-induced oxaliplatin resistance were investigated by flow cytometry, colony formation, viability of pancreatic cancer organoids in vitro and by xenograft models in vivo. RNA pulldown, RNA immunoprecipitation, and sites mutation assays were used to reveal the underlying mechanism. @@@ Results We identified a circRNA, circBIRC6, is significantly upregulated in CAF-derived EVs and is positively associated with oxaliplatin-based chemoresistance. In vitro and in vivo functional assays showed that CAF-derived EV-packaged circBIRC6 enhance oxaliplatin resistance of pancreatic cancer cells and organoids via regulating the non-homologous end joining (NHEJ) dependent DNA repair. Mechanistically, circBIRC6 directly binds with XRCC4 and enhanced the interaction of XRCC4 with SUMO1 at the lysine 115 residue, which facilitated XRCC4 chromatin localization. XRCC4(K115R) mutation dramatically abrogated the EV-packaged circBIRC6 induced effect. Moreover, combination of antisense oligonucleotide inhibitors against circBIRC6 with Olaparib dramatically suppressed chemoresistance in patient-derived xenograft models. @@@ Conclusions Our study revealed that EV-packaged circBIRC6 confer oxaliplatin resistance in PDAC by mediating SUMOylation of XRCC4, introducing a promising predictive and therapeutic target for PDAC on oxaliplatin resistance.

学科与关键词

关键词
Extracellular vesiclesCancer-associated fibroblastsCircular RNAsNon-homologous end joiningSUMOylationOxaliplatin resistance
相关
加载中…
  • Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair
    Zhang, Xiang; Zheng, Shangyou; Hu, Chonghui; Li, Guolin; Lin, Hongcao; Xia, Renpeng; Ye, Yuancheng; He, Rihua; Li, Zhihua; Lin, Qing*; Chen, Rufu*; Zhou, Quanbo*Oncogene, 2022, 41(16): 2372-2389.被引 22
  • circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis
    Hu, Chonghui; Xia, Renpeng; Zhang, Xiang; Li, Tingting; Ye, Yuancheng; Li, Guolin; He, Rihua; Li, Zhihua; Lin, Qing*; Zheng, Shangyou*; Chen, Rufu*Molecular Cancer, 2022, 21(1): 24.被引 57
  • A Novel Protein Encoded by Exosomal CircATG4B Induces Oxaliplatin Resistance in Colorectal Cancer by Promoting Autophagy
    Pan, Zihao; Zheng, Jun; Zhang, Jiebin; Lin, Jiatong; Lai, Jianguo; Lyu, Zejian; Feng, Huolun; Wang, Junjiang*; Wu, Deqing*; Li, Yong*Advanced Science, 2022, 9(35).被引 26
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
发表日期
2023-11-28
卷期
第 42 卷, 第 1 期
页码
324
DOI
10.1186/s13046-023-02854-3
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China

作者

  • Z

    Zheng, Shangyou (第一作者)

    guangdong prov peoples hosp · southern med univ

  • T

    Tian, Qing

查看全部 13 位作者收起作者
  • Y

    Yuan, Yuan

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • S

    Sun, Shuxin

    guangdong prov peoples hosp · southern med univ

  • L

    Li, Tingting

  • X

    Xia, Renpeng

    2 · southern med univ

  • H

    He, Rihua

    shantou univ · guangdong prov peoples hosp · southern med univ

  • L

    Luo, Yuming

    guangdong prov peoples hosp · southern med univ

  • L

    Lin, Qing

    guangdong prov peoples hosp · southern med univ

  • F

    Fu, Zhiqiang

    sun yat sen univ

  • Z

    Zhou, Yu (通讯)

    guangdong prov peoples hosp · southern med univ

  • C

    Chen, Rufu (通讯)

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • H

    Hu, Chonghui (通讯)

    guangdong prov peoples hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417